BioMarin Pharmaceutical
BMRN
#1924
Rank
A$15.17 B
Marketcap
A$78.42
Share price
-0.17%
Change (1 day)
-2.97%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2026 (TTM): A$0.21 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are A$3.40 Billion. In 2025 the company made an earning of A$0.69 Billion a decrease over its 2024 earnings that were of A$0.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.21 B-69.23%
2025 A$0.69 B-10.94%
2024 A$0.77 B187.31%
2023 A$0.26 B26.07%
2022 A$0.21 B-298.51%
2021 -A$0.11 Billion78.04%
2020 -A$60.57 Million-55.36%
2019 -A$0.14 Billion-33.56%
2018 -A$0.21 Billion297.78%
2017 -A$51.35 Million-95.68%
2016 -A$1.19 Billion437.12%
2015 -A$0.23 Billion23.91%
2014 -A$0.18 Billion-29.25%
2013 -A$0.26 Billion49.23%
2012 -A$0.17 Billion171.11%
2011 -A$62.44 Million103.01%
2010 -A$30.76 Million-3903.54%
2009 A$0.8 M-98.31%
2008 A$47.83 M-189.7%
2007 -A$53.33 Million51.02%
2006 -A$35.32 Million-61.58%
2005 -A$91.9 Million-56.59%
2004 -A$0.22 Billion95.13%
2003 -A$0.11 Billion12.09%
2002 -A$96.78 Million73.19%
2001 -A$55.89 Million18.32%
2000 -A$47.23 Million19.65%
1999 -A$39.48 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
A$10.24 B 4,702.02%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-A$0.73 Billion-439.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-A$0.16 Billion-173.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$0.11 B-46.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$0.27 M-99.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$0.42 B 98.82%๐Ÿ‡บ๐Ÿ‡ธ USA